TUCKER LAWRENCE C 4
4 · NATIONAL HEALTHCARE CORP · Filed Nov 13, 2018
Insider Transaction Report
Form 4
TUCKER LAWRENCE C
Director
Transactions
- Award
Option to purchase common stock
2018-11-08+3,200→ 3,200 totalExercise: $61.25Exp: 2020-05-06→ Common Stock (3,200 underlying) - Award
Option to purchase common stock
2018-11-08+7,500→ 7,500 totalExercise: $72.94Exp: 2022-05-08→ Common Stock (7,500 underlying) - Disposition to Issuer
Option to purchase common stock
2018-11-08−7,500→ 0 totalExercise: $61.90Exp: 2023-05-02→ Common Stock (7,500 underlying) - Award
Option to purchase common stock
2018-11-08+7,500→ 7,500 totalExercise: $61.90Exp: 2023-05-02→ Common Stock (7,500 underlying) - Disposition to Issuer
Option to purchase common stock
2018-11-08−3,200→ 0 totalExercise: $61.25Exp: 2020-05-06→ Common Stock (3,200 underlying) - Disposition to Issuer
Option to purchase common stock
2018-11-08−7,500→ 0 totalExercise: $62.78Exp: 2021-06-01→ Common Stock (7,500 underlying) - Award
Option to purchase common stock
2018-11-08+7,500→ 7,500 totalExercise: $62.78Exp: 2021-06-01→ Common Stock (7,500 underlying) - Disposition to Issuer
Option to purchase common stock
2018-11-08−7,500→ 0 totalExercise: $72.94Exp: 2022-05-08→ Common Stock (7,500 underlying)
Holdings
- 154,300
Shares of Common Stock
Footnotes (1)
- [F1]The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d).